Anne F Schott

Clinical Professor of Medicine, Deputy Chair, SWOG, The Hope Foundation, Chair of Board of Directors

  • 4499 Citations
  • 25 h-Index
1984 …2020

Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1995 2020

Research Output 1984 2018

Concurrent veliparib with chest wall and nodal radiotherapy in patients with inflammatory or locoregionally recurrent breast cancer: The TBCRC 024 phase I multicenter study

The Translational Breast Cancer Research Consortium May 1 2018 In : Journal of Clinical Oncology. 36, 13, p. 1317-1322 6 p.

Research output: Contribution to journalArticle

Thoracic Wall
Multicenter Studies
Radiotherapy
Breast Neoplasms
Lymph Nodes
2 Citations

Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor-associated arthralgias in early-stage breast cancer: SWOG S1202

Henry, N. L., Unger, J. M., Schott, A. F., Fehrenbacher, L., Flynn, P. J., Prow, D. M., Sharer, C. W., Burton, G. V., Kuzma, C. S., Moseley, A., Lew, D. L., Fisch, M. J., Moinpour, C. M., Hershman, D. L. & Wade, J. L. Feb 1 2018 In : Journal of Clinical Oncology. 36, 4, p. 326-332 7 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Controlled Clinical Trials
Arthralgia
Placebos
Breast Neoplasms
36 Citations

Integrative clinical genomics of metastatic cancer

Robinson, D. R. , Wu, Y. M. , Lonigro, R. J. , Vats, P. , Cobain, E. , Everett, J. , Cao, X. , Rabban, E. , Kumar-Sinha, C. , Raymond, V. , Schuetze, S. , Alva, A. , Siddiqui, J. , Chugh, R. , Worden, F. , Zalupski, M. M. , Innis, J. , Mody, R. J. , Tomlins, S. A. , Lucas, D. & 13 others Baker, L. H., Ramnath, N., Schott, A. F., Hayes, D. F., Vijai, J., Offit, K., Stoffel, E. M., Roberts, J. S., Smith, D. C., Kunju, L. P., Talpaz, M., Cieślik, M. & Chinnaiyan, A. M. Aug 17 2017 In : Nature. 548, 7667, p. 297-303 7 p.

Research output: Contribution to journalArticle

Genomics
Neoplasms
Exome
RNA Sequence Analysis
Tumor Microenvironment
6 Citations

Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2–negative metastatic breast cancer

Schott, A. F., Goldstein, L. J., Cristofanilli, M., Ruffini, P. A., McCanna, S., Reuben, J. M., Perez, R. P., Kato, G. & Wicha, M. Sep 15 2017 In : Clinical Cancer Research. 23, 18, p. 5358-5365 8 p.

Research output: Contribution to journalArticle

Paclitaxel
Breast Neoplasms
Neoplastic Stem Cells
Pharmacokinetics
Chemokine Receptors
1 Citations

Adjuvant trastuzumab benefit in patients diagnosed with triple-positive breast cancer

Schott, A. F. Aug 1 2016 In : JAMA Oncology. 2, 8, p. 1047-1048 2 p.

Research output: Contribution to journalComment/debate

ErbB-2 Receptor
Breast Neoplasms
Trastuzumab